Navigation Links
AUDIO from Medialink and Safe Kids Worldwide: Teaming Up to Keep Kids Safe Around Cars
Date:12/20/2007

NEW YORK, Aug. 10 /PRNewswire/ -- Children may love going for rides in cars and trucks, but they also may not fully understand how to stay safe around them. Federal statistics show motor vehicle crashes are the leading cause of death in children ages two to fourteen. "Safe Kids Buckle Up," a program of Safe Kids Worldwide in collaboration with General Motors, has been educating families on safety in and around vehicles for ten years.

Listen to this report from Safe Kids Worldwide at: http://media.medialink.com/WebNR.aspx?story=33698

Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://media.medialink.com.

08NY07-0033


'/>"/>
SOURCE Medialink and Safe Kids Worldwide
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. AUDIO from Medialink and Radica: Staying Sharp with Games for Your Brain
2. AUDIO from Medialink and Kelloggs: Whats in Your Water?
3. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
4. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
5. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
6. AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care
7. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
8. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
9. AUDIO from Medialink and Kelloggs: The Jeans Dont Lie
10. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
11. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...r-old woman in British Columbia died a lonely deat...lbo, one of her sons, is hopeful that his mom’s de... care to the senior citizens. The hospital separa...ho was also being treated at the same hospital, Ko...
... in London are all set to make a go to build a sec...nada after losing a bid to build it in their own c...y be accommodated, according to David Sloman, pote...London. Shriners in Montreal are a bit apprehensiv...
...potato' burning bright in the hands of you could p...es.According to a long-term study of nearly 85 000...s’ //found that those with the highest potato inta... developing type 2 diabetes. Obese women, who are...
...udy appearing in online edition of Gut, a journal ...elly fat may raise the risk of gallstones in older...ominal circumference and waist-to- hip ratio were ...d risk of gallstones and gall bladder removal or c...
Other Medicine News:
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmetics a...ewswire/ -- MatTek Corp. today announced,that resu...laboratory,"catch-up" validation study on MatTek,s...e test results demonstrated the required sensitivi... validated alternative to animal,testing for deter...
(Date:10/8/2008)...eview Zanolimumab Program to be Discontinued and H...the Results of its Portfolio Review; Zanolimumab ...duce the Number of E...Call/ -- Genmab A/S (OMX: GEN),announced today tha...HuMax-CD4(R)). In addition, as a result of a portf...
(Date:10/8/2008)... Findings Confirm Potency of Poly-ICR as Va...stCall/ -- Nventa Biopharmaceuticals,Corporation (...inical,studies using its proprietary Toll-like Rec... at the World Vaccine Congress 2008 in Lyon, Franc...ent vaccine adjuvant,targeting the Toll-like Recep...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Prometheus Lab..., today announced findings from its,development of...blood test,for irritable bowel syndrome (IBS). The...pression of particular biomarkers in blood samples...ion of these biomarkers,combined with a proprieta...
Breaking Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Spherix Receives NASDAQ Bid Price Deficiency Letter 6686 1Spherix Receives NASDAQ Bid Price Deficiency Letter 6686 2Simple Procedure Improves Male Fertility 24302 1Simple Procedure Improves Male Fertility 24302 2Simple Procedure Improves Male Fertility 24302 3Rock The Cradles Bad Boy Landon Brown Owes His Irresistible New Smile to Dr Michael Kosdon 24297 1Rock The Cradles Bad Boy Landon Brown Owes His Irresistible New Smile to Dr Michael Kosdon 24297 2Alameda County Hosts National Initiative to Reduce Health Disparities 24295 1Alameda County Hosts National Initiative to Reduce Health Disparities 24295 2
...could offer protection,for infants against Haemop... , , TORONTO, Canada, May 11, , 2007 &mdas...Phase II vaccine clinical study presented this wee... Annual Meeting in,Toronto, Canada. The new data s...ne holds potential to protect infants in the,first...
...WIRE)--May 14, 2007 - Oculus Innovative,Sciences, ...n,Technology was the subject of a poster presentat...EWMA) conference that was held in,Glasgow, Scotlan...esults About an Antimicrobial,Solution in the Trea... & Harding infection criteria to evaluate the,...
Other Medicine Technology:GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 2GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 4GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 5Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3
Phaco chopper 1 mm fully cutting edge.
Round handle dull finish. For right handed surgeon.
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm.
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand.
Medicine Products: